This is a Validated Antibody Database (VAD) review about human GNRHR, based on 4 published articles (read how Labome selects the articles), using GNRHR antibody in all methods. It is aimed to help Labome visitors find the most suited GNRHR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
GNRHR synonym: GNRHR1; GRHR; HH7; LHRHR; LRHR

Invitrogen
mouse monoclonal (GNRH03)
  • western blot; human; 1:100
In order to evaluate the effect of degarelix on human prostate cell growth, Invitrogen GNRHR antibody (Thermo Fisher Scientific, MA5-11538) was used in western blot on human samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (GNRH03)
  • immunohistochemistry - paraffin section; human; 1:100
In order to determine the expression of LHRH receptor, progesterone receptor, and Ki67 labeling index in patients with meningioma, Invitrogen GNRHR antibody (Thermo Scientific, MS-1139-P) was used in immunohistochemistry - paraffin section on human samples at 1:100. Prostate Cancer Prostatic Dis (2013) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 1d
  • western blot; human; loading ...; fig 1e
Abcam GNRHR antibody (Abcam, ab183079) was used in immunohistochemistry on human samples at 1:100 (fig 1d) and in western blot on human samples (fig 1e). Front Oncol (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:50; fig s1f
Abcam GNRHR antibody (Abcam, ab183079) was used in immunohistochemistry on human samples at 1:50 (fig s1f). Sci Rep (2016) ncbi
Articles Reviewed
  1. Liu Q, Zhou X, Feng W, Pu T, Li X, Li F, et al. Gonadotropin-Releasing Hormone Receptor-Targeted Near-Infrared Fluorescence Probe for Specific Recognition and Localization of Peritoneal Metastases of Ovarian Cancer. Front Oncol. 2020;10:266 pubmed publisher
  2. Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, et al. A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression. Sci Rep. 2016;6:25408 pubmed publisher
  3. Sakai M, Martinez Arguelles D, Patterson N, Chaurand P, Papadopoulos V. In search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growth. PLoS ONE. 2015;10:e0120670 pubmed publisher
  4. Li Q, Coulson H, Klaassen Z, Sharma S, Ramalingam P, Moses K, et al. Emerging association between androgen deprivation therapy and male meningioma: significant expression of luteinizing hormone-releasing hormone receptor in male meningioma. Prostate Cancer Prostatic Dis. 2013;16:387-90 pubmed publisher